Cargando…

Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy

Detalles Bibliográficos
Autor principal: Fioredda, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460396/
https://www.ncbi.nlm.nih.gov/pubmed/23049435
http://dx.doi.org/10.5581/1516-8484.20120065
_version_ 1782244937059794944
author Fioredda, Francesca
author_facet Fioredda, Francesca
author_sort Fioredda, Francesca
collection PubMed
description
format Online
Article
Text
id pubmed-3460396
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Associação Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-34603962012-10-04 Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy Fioredda, Francesca Rev Bras Hematol Hemoter Scientific Comments Associação Brasileira de Hematologia e Hemoterapia 2012 /pmc/articles/PMC3460396/ /pubmed/23049435 http://dx.doi.org/10.5581/1516-8484.20120065 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Scientific Comments
Fioredda, Francesca
Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
title Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
title_full Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
title_fullStr Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
title_full_unstemmed Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
title_short Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
title_sort immunity against hepatitis b and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
topic Scientific Comments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460396/
https://www.ncbi.nlm.nih.gov/pubmed/23049435
http://dx.doi.org/10.5581/1516-8484.20120065
work_keys_str_mv AT fioreddafrancesca immunityagainsthepatitisbandmeaslesvaccinationafterchemotherapyforacutelymphoblasticleukaemiainchildrenrevaccinationpolicy